Data completeness
0/8 — Limited
Drug data last refreshed 49m ago · AI intelligence enriched 22h ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Parasal Sodium is an oral tablet formulation of aminosalicylate sodium, a small-molecule anti-inflammatory agent. The drug is in pre-launch stage under Century Therapeutics sponsorship. Specific therapeutic indications and mechanism of action are not currently documented in available data.
Pre-Launch
Pre-launch stage indicates emerging team building phase; manufacturing and operational roles are currently prioritized with limited commercial headcount expansion visible.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on Parasal Sodium at this pre-launch stage offers opportunity to build foundational operational and manufacturing infrastructure for a new product launch. Current hiring focus in manufacturing and senior director roles signals investment in supply chain and quality systems ahead of commercialization.
Director
Worked on PARASAL SODIUM at Century Therapeutics? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.